<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Cancer</journal-id>
    <journal-title-group>
      <journal-title>BMC Cancer</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2407</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6995241</article-id>
    <article-id pub-id-type="publisher-id">6533</article-id>
    <article-id pub-id-type="doi">10.1186/s12885-020-6533-0</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Almeida</surname>
          <given-names>Palloma Porto</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cardoso</surname>
          <given-names>Cristina Padre</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4327-2922</contrib-id>
        <name>
          <surname>de Freitas</surname>
          <given-names>Leandro Martins</given-names>
        </name>
        <address>
          <email>leandromartins@ufba.br</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label>Núcleo de Biointegração, Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista, Brazil </aff>
      <aff id="Aff2"><label>2</label>Faculdade Santo Agostinho, Vitória da Conquista, Brazil </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>31</day>
      <month>1</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>31</day>
      <month>1</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>20</volume>
    <elocation-id>82</elocation-id>
    <history>
      <date date-type="received">
        <day>9</day>
        <month>7</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>13</day>
        <month>1</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s). 2020</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Although the pancreatic ductal adenocarcinoma (PDAC) presents high mortality and metastatic potential, there is a lack of effective therapies and a low survival rate for this disease. This PDAC scenario urges new strategies for diagnosis, drug targets, and treatment.</p>
      </sec>
      <sec>
        <title>Methods</title>
        <p id="Par2">We performed a gene expression microarray meta-analysis of the tumor against normal tissues in order to identify differentially expressed genes (DEG) shared among all datasets, named core-genes (CG). We confirmed the CG protein expression in pancreatic tissue through The Human Protein Atlas. It was selected five genes with the highest area under the curve (AUC) among these proteins with expression confirmed in the tumor group to train an artificial neural network (ANN) to classify samples.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par3">This microarray included 461 tumor and 187 normal samples. We identified a CG composed of 40 genes, 39 upregulated, and one downregulated. The upregulated CG included proteins and extracellular matrix receptors linked to actin cytoskeleton reorganization. With the Human Protein Atlas, we verified that fourteen genes of the CG are translated, with high or medium expression in most of the pancreatic tumor samples. To train our ANN, we selected the best genes (AHNAK2, KRT19, LAMB3, LAMC2, and S100P) to classify the samples based on AUC using mRNA expression. The network classified tumor samples with an f1-score of 0.83 for the normal samples and 0.88 for the PDAC samples, with an average of 0.86. The PDAC-ANN could classify the test samples with a sensitivity of 87.6 and specificity of 83.1.</p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p id="Par4">The gene expression meta-analysis and confirmation of the protein expression allow us to select five genes highly expressed PDAC samples. We could build a python script to classify the samples based on RNA expression. This software can be useful in the PDAC diagnosis.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Pancreatic ductal adenocarcinoma</kwd>
      <kwd>Artificial neural network</kwd>
      <kwd>Meta-analysis</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002322</institution-id>
            <institution>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2020</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par23">The pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic cancer histological subtype with high mortality due to the lack of symptoms in the initial phase of the disease and its aggressive progression [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. PDAC development is directly related to <italic>KRAS</italic> overexpression [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], along with the inactivation of the tumor-suppressor genes <italic>CDKN2A/p16</italic> [<xref ref-type="bibr" rid="CR4">4</xref>], <italic>SMAD4/DPC4</italic> [<xref ref-type="bibr" rid="CR5">5</xref>] and <italic>TP53</italic> [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. The <italic>KRAS</italic> activation is considered significant in PDAC progression, and many efforts were made to inhibit its activity [<xref ref-type="bibr" rid="CR8">8</xref>]; nevertheless, it seems to be undruggable [<xref ref-type="bibr" rid="CR9">9</xref>]. Data have been presented in the literature over integrated analysis about PDAC genes and proteins, classifying PDAC in different molecular subtypes among patients [<xref ref-type="bibr" rid="CR10">10</xref>], and through integrated genome analyses that reinforce the participation of <italic>KRAS, TP53, SMAD4,</italic> and <italic>CDKN2A</italic> in a subset of PDAC tumors [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
    <p id="Par24">Since there is a lack of effective therapies and a low survival rate, the research for new biomarkers and therapies targets in PDAC remains active [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. There are some gene expression changes in pancreatic cancer already described and presented as biological markers. The genes in the ribosome and the spliceosome pathway (ribosomal protein genes Nup170, Nup160, and HNRNPU) were described as potential biomarkers [<xref ref-type="bibr" rid="CR15">15</xref>]. The meta-analysis of PDAC microarray data could identify five biomarkers (TMPRSS4, AHNAK2, POSTN, ECT2, and SERPINB5) that classified the PDAC and normal samples with sensitivity of 94%, and specificity of 89.6% [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
    <p id="Par25">Advances in high-performance computing, such as system biology and artificial intelligence (AI) allows integration of data and pattern recognition that generates not only new understating about diseases, but support new targets discovery and biomarkers development for future treatments [<xref ref-type="bibr" rid="CR17">17</xref>]. The potential to classify the cancer samples using gene expression, methylation information, and AI has been used in other types of cancer studies with promising results. The application of these studies would improve the classification of the samples in tumor diagnosis and subtyping [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR20">20</xref>]. The studies using automatic technics to predict risk/diagnosis had demonstrated a high classification performance, presenting sensitivity &gt; 90% [<xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR24">24</xref>].</p>
    <p id="Par26">The high number of features coming from microarray gene expression and methylation genomic information used to train AI tumor diagnosis models can give good results in the classification of samples [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], lowering the false-negative rate in training and validation samples. However, the high number of features can make the diagnosis available only for samples with thousands of gene expression values [<xref ref-type="bibr" rid="CR18">18</xref>]. It has been shown that reducing the number of features can give the same or better results than using thousands of features [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p>
    <p id="Par27">The application of AI in pancreatic tumor must improve the early diagnostic and, consequently, the treatment and patient survival. The AI has been used to predict risk/diagnosis using pancreatic image and personal health features [<xref ref-type="bibr" rid="CR27">27</xref>]. The prediction of pancreatic cancer risk in patients with type 2 diabetes was compared using logistic regression and ANN, again using personal health features and presenting the performance of models predicting the cancer risk factor [<xref ref-type="bibr" rid="CR24">24</xref>]. There are also AI models to diagnose pancreatic cancer-based in four plasma proteins selected in mass spectra, showing the potential of AI in predicting the status of a sample based on biological markers with high sensitivity (90.9%) and specificity (91.1%) [<xref ref-type="bibr" rid="CR22">22</xref>]. The Lustgarten Foundation, created to pancreatic cancer research, pointed out the importance of including the AI in the PDAC diagnosis based on MRI and CT scans [<xref ref-type="bibr" rid="CR28">28</xref>]. The use of new technologies to help pancreatic cancer risk/diagnosis must be pursued, and it would improve patients’ survival. The gene expression changes in pancreatic cancer could be used as biological markers and help in the diagnosis and be used to build a computational model using AI to predict sample status.</p>
    <p id="Par28">In this paper, we performed a meta-analysis of gene expression of public microarray data. We identified a core-gene (CG) group and accessed the protein expression through the Protein Atlas database based on immunohistochemical (IHC) staining images. Clusterization methods were applied to distinguish between normal and PDAC samples. It was selected five genes combining microarray expression and Protein Atlas information. The gene expression information from PDAC and normal samples were used to build an ANN (PDAC-ANN). The PDAC-ANN uses gene expression information to predict the sample status (normal or PDAC) and give the probability of the sample be PDAC. This is the first time gene expression is used to build an ANN model to predict PDAC diagnosis. The results showed here must be verified in a large sample and could be used in the discrimination of samples using these markers. This PDAC-ANN is free software and could be used to improve the diagnosis and help PDAC patients.</p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <sec id="Sec3">
      <title>Dataset acquisition</title>
      <p id="Par29">The microarray expression data of human healthy and pancreatic cancer tissue were collected from Gene Expression Omnibus (GEO) (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo</ext-link>) using the search term “pancreatic ductal adenocarcinoma” and selecting mRNA expression profiling by an array. The ten datasets (Table <xref rid="Tab1" ref-type="table">1</xref>) were selected following the criteria: inclusion of (1) studies presenting PDAC/normal samples from the pancreas; exclusion of studies (2) with induced mutations or activated pathways; (3) cells previously exposed to chemotherapy drugs. These criteria ensure that the expression alterations were provided only from the shift normal/disease, and not due to induced mutations in cell lineage or chemotherapy treatment. The datasets were loaded into the R software [<xref ref-type="bibr" rid="CR39">39</xref>] using the GEOquery package [<xref ref-type="bibr" rid="CR40">40</xref>]. Ten studies were analyzed to find DEG, and two independent microarray studies provided samples to validate the CG derived from the meta-analysis.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of studies used in the meta-analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Accession number</th><th>Study</th><th>Array platform</th><th colspan="2">Differentially expressed genes</th><th colspan="2">Samples</th></tr><tr><th colspan="3"/><th>Upregulated</th><th>Downregulated</th><th>Tumor</th><th>Normal</th></tr></thead><tbody><tr><td>GSE23397</td><td>*</td><td rowspan="3">Affymetrix Human Exon 1.0 ST Array</td><td>4031</td><td>870</td><td>15</td><td>6</td></tr><tr><td>GSE28735</td><td>[<xref ref-type="bibr" rid="CR29">29</xref>]</td><td>245</td><td>146</td><td>45</td><td>45</td></tr><tr><td>GSE41368</td><td>[<xref ref-type="bibr" rid="CR30">30</xref>]</td><td>1200</td><td>462</td><td>6</td><td>6</td></tr><tr><td>GSE32676</td><td>[<xref ref-type="bibr" rid="CR31">31</xref>]</td><td rowspan="3">Affymetrix Human Genome U133 Plus 2.0 Array</td><td>686</td><td>319</td><td>25</td><td>7</td></tr><tr><td>GSE71989</td><td>[<xref ref-type="bibr" rid="CR32">32</xref>]</td><td>3052</td><td>661</td><td>13</td><td>8</td></tr><tr><td>GSE15471</td><td>[<xref ref-type="bibr" rid="CR33">33</xref>]</td><td>1546</td><td>227</td><td>39</td><td>39</td></tr><tr><td>GSE62165</td><td>[<xref ref-type="bibr" rid="CR13">13</xref>]</td><td>Affymetrix Human Genome U219 Array</td><td>2638</td><td>1266</td><td>118</td><td>13</td></tr><tr><td>GSE43795</td><td>[<xref ref-type="bibr" rid="CR34">34</xref>]</td><td>Illumina HumanHT-12 V4.0 expression beadchip</td><td>1978</td><td>1343</td><td>6</td><td>5</td></tr><tr><td>GSE71729</td><td>[<xref ref-type="bibr" rid="CR35">35</xref>]</td><td>Agilent-014850 Whole Human Genome Microarray 4x44K G4112F</td><td>285</td><td>175</td><td>145</td><td>46</td></tr><tr><td>GSE60979</td><td>[<xref ref-type="bibr" rid="CR36">36</xref>]</td><td>Agilent-028004 SurePrint G3 Human GE 8x60K Microarray</td><td>1365</td><td>1336</td><td>49</td><td>12</td></tr><tr><td>Total</td><td/><td/><td/><td/><td>461</td><td>187</td></tr><tr><td>GSE16515</td><td>[<xref ref-type="bibr" rid="CR37">37</xref>]</td><td>Affymetrix Human Genome U133 Plus 2.0 Array</td><td rowspan="2">–</td><td rowspan="2">–</td><td>36</td><td>16</td></tr><tr><td>GSE62452</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>]</td><td>Affymetrix Human Gene 1.0 ST Array</td><td>69</td><td>61</td></tr><tr><td>Total</td><td/><td/><td/><td/><td>105</td><td>77</td></tr></tbody></table><table-wrap-foot><p>* No publication available</p><p>- Analysis of differentially expressed genes was not applied to the validation dataset</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec4">
      <title>Data processing</title>
      <p id="Par30">Non-specific filtering and identification of differentially expressed genes (DEG) were applied to each dataset coming from the same GEO series using packages from Bioconductor [<xref ref-type="bibr" rid="CR41">41</xref>]. Briefly, the package genefilter was used to remove the genes with no expression variation among samples [<xref ref-type="bibr" rid="CR42">42</xref>], followed by the collapse of multiple probe measurements of a given gene into a single gene measurement in package WGCNA [<xref ref-type="bibr" rid="CR43">43</xref>]. The limma package [<xref ref-type="bibr" rid="CR44">44</xref>] was used to identify the DEG through a t-test. We considered DEGs when log2 fold change (log2FC) was ≥1 and adjusted <italic>p</italic>-value by false discovery rate (FDR) ≤ 0.05 [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>].</p>
    </sec>
    <sec id="Sec5">
      <title>Core-gene analysis</title>
      <p id="Par31">The DEG frequency among the microarray studies was retrieved, and those shared by all microarray studies were considered as the CG. The CG expression values were standardized, applying the method <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {X}^{\prime }=\frac{X-\overline{X}}{sd} $$\end{document}</tex-math><mml:math id="M2" display="inline"><mml:msup><mml:mi>X</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>X</mml:mi><mml:mo>−</mml:mo><mml:mover accent="false"><mml:mi>X</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mi mathvariant="italic">sd</mml:mi></mml:mfrac></mml:math><inline-graphic xlink:href="12885_2020_6533_Article_IEq1.gif"/></alternatives></inline-formula>, where <italic>X</italic> represents the expression values, <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \overline{X} $$\end{document}</tex-math><mml:math id="M4" display="inline"><mml:mover accent="false"><mml:mi>X</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="12885_2020_6533_Article_IEq2.gif"/></alternatives></inline-formula> the gene expression average, and <italic>sd</italic> standard deviation [<xref ref-type="bibr" rid="CR47">47</xref>]. This standardization was followed by a min-max data rescale, for each gene transforming all values to [0, 1] range. Thus, restricting values from different studies to the same range [<xref ref-type="bibr" rid="CR48">48</xref>]. The CG standardized values were used in the Principal Component Analysis (PCA) and the hierarchical clustering in order to check the clustering of the samples from all datasets based on the CG expression values.</p>
    </sec>
    <sec id="Sec6">
      <title>Data validation</title>
      <p id="Par32">The IHC staining images and the protein expression data from pancreatic cancer tissue were used as validation of the CG. Protein expression data were obtained from the Human Protein Atlas (HPA) (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org">www.proteinatlas.org</ext-link>) [<xref ref-type="bibr" rid="CR49">49</xref>]. The number of IHC staining images present in HPA categories (high, medium, low, not detected) was counted to each gene. These IHC staining images were used as validation of protein expression when the number of high plus medium stating images was ≥75%.</p>
      <p id="Par33">We also investigated a validation using the CG mRNA standardized values in two independent datasets (GSE16515 and GSE62452). We applied the hierarchical clustering/heatmap, PCA, and artificial neural network to the validation samples to evaluate its capability to differentiate tumor and normal groups using the microarray information.</p>
    </sec>
    <sec id="Sec7">
      <title>Neural network sample classification</title>
      <p id="Par34">We build an artificial neural network (ANN) using python to classify the sample in normal or tumor samples. The ANN was trained using normalized gene expression values [0, 1] from the five genes with the highest AUC among the CG confirmed by HPA (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). We explore the performances of 90 network architectures with one input layer with five nodes (input neurons to gene expression values), one or two hidden layers varying the number of nodes from 2 to 10, and two output nodes, giving the normal and PDAC probability. Each network architecture was trained 30 times, and we took the mean accuracy in the train set to evaluate the classification performance. We used a learning rate of 0.05, 100 epochs during training, relu and softmax as activation functions for internal and output node, respectively. The network weights were randomly initialized with values between [− 1, 1], and bias with value 1.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Artificial neural network architecture. A graphical representation of a fully connected artificial intelligence algorithm (PDAC-ANN). PDAC-ANN is a set of mathematical equations; in each layer, it transforms expression values up to the last layer. The expression values from AHNAK2, KRT19, LAMB2, LAMC2, and S100P genes are data inserted in the input layer (green neurons), the hidden layers (blue neurons) process the expression values, and the output layer (red neurons) give the classification in normal or PDAC sample as a probability</p></caption><graphic xlink:href="12885_2020_6533_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec8">
      <title>Statistics and analysis</title>
      <p id="Par35">Results are presented as a bar plot, representing the protein expression as indicated in the HPA, and PCA or heatmap, representing the variation and clusterization among the samples based on mRNA gene expression. The IHC results graph, PCA, and heatmap were produced using the R statistical computational language [<xref ref-type="bibr" rid="CR50">50</xref>] and the ggplot2 package [<xref ref-type="bibr" rid="CR51">51</xref>]. The statistical tests (ROC, AUC, and DEG) and <italic>p</italic>-value correction were performed using the R language. The sensitivity, sensibility, and accuracy were calculated using python language, getting the results from the confusion matrix in training and validation datasets.</p>
    </sec>
  </sec>
  <sec id="Sec9">
    <title>Results</title>
    <sec id="Sec10">
      <title>Differentially expressed genes in meta-analysis</title>
      <p id="Par36">To profile differentially expressed genes in PDAC, we performed a meta-analysis of microarray data available in Table <xref rid="Tab1" ref-type="table">1</xref>. We collected and compared 463 tumor samples to 187 normal tissues. We have identified 10,861 unique DEG, where 7028 were upregulated and 3833 downregulated genes (log2FC = 1; adj. <italic>p</italic>-value ≤0.05) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). The ten studies shared 40 DEG (CG), where 39 were upregulated, and one downregulated (Table <xref rid="Tab2" ref-type="table">2</xref>).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Description of the core-genes involved in the PDAC biological process</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene symbol</th><th>Gene name</th><th>Gene symbol</th><th>Gene name</th></tr></thead><tbody><tr><td colspan="4"><italic>Upregulated</italic></td></tr><tr><td> AHNAK2</td><td>AHNAK nucleoprotein 2</td><td>KRT19</td><td>keratin 19</td></tr><tr><td> ANLN</td><td>anillin actin binding protein</td><td>LAMA3</td><td>laminin subunit alpha 3</td></tr><tr><td> ANO1</td><td>anoctamin 1</td><td>LAMB3</td><td>laminin subunit beta 3</td></tr><tr><td> ASPM</td><td>abnormal spindle microtubule assembly</td><td>LAMC2</td><td>laminin subunit gamma 2</td></tr><tr><td> CAPG</td><td>capping actin protein, gelsolin like</td><td>LCN2</td><td>lipocalin 2</td></tr><tr><td> CEACAM5</td><td>carcinoembryonic antigen related cell adhesion molecule 5</td><td>MET</td><td>MET proto-oncogene, receptor tyrosine kinase</td></tr><tr><td> CEACAM6</td><td>carcinoembryonic antigen related cell adhesion molecule 6</td><td>NQO1</td><td>NAD(P)H quinone dehydrogenase 1</td></tr><tr><td> COL10A1</td><td>collagen type X alpha 1 chain</td><td>OAS1</td><td>2′-5′-oligoadenylate synthetase 1</td></tr><tr><td> CXCL5</td><td>C-X-C motif chemokine ligand 5</td><td>S100A14</td><td>S100 calcium binding protein A14</td></tr><tr><td> DKK1</td><td>dickkopf WNT signaling pathway inhibitor 1</td><td>S100P</td><td>S100 calcium binding protein P</td></tr><tr><td> FXYD3</td><td>FXYD domain containing ion transport regulator 3</td><td>SERPINB5</td><td>serpin family B member 5</td></tr><tr><td> GABRP</td><td>gamma-aminobutyric acid type A receptor pi subunit</td><td>SLC2A1</td><td>solute carrier family 2 member 1</td></tr><tr><td> GCNT3</td><td>glucosaminyl (N-acetyl) transferase 3, mucin type</td><td>SLC44A4</td><td>solute carrier family 44 member 4</td></tr><tr><td> GJB2</td><td>gap junction protein beta 2</td><td>SLC6A14</td><td>solute carrier family 6 member 14</td></tr><tr><td> GPRC5A</td><td>G protein-coupled receptor class C group 5 member A</td><td>SLPI</td><td>secretory leukocyte peptidase inhibitor</td></tr><tr><td> GPX2</td><td>glutathione peroxidase 2</td><td>TCN1</td><td>transcobalamin 1</td></tr><tr><td> IFI27</td><td>interferon alpha inducible protein 27</td><td>TFF1</td><td>trefoil factor 1</td></tr><tr><td> ITGA2</td><td>integrin subunit alpha 2</td><td>TMC5</td><td>transmembrane channel like 5</td></tr><tr><td> ITGA3</td><td>integrin subunit alpha 3</td><td>TMPRSS4</td><td>transmembrane protease, serine 4</td></tr><tr><td/><td/><td>TSPAN1</td><td>tetraspanin 1</td></tr><tr><td colspan="4"><italic>Downregulated</italic></td></tr><tr><td> AOX1</td><td>aldehyde oxidase 1</td><td/><td/></tr></tbody></table></table-wrap></p>
      <p id="Par37">The CG showed a profile of upregulated genes functions related to cell membrane-ECM interaction (<italic>LAMA3</italic>, <italic>LAMB3, LAMC2</italic>), cytoskeleton interaction/calcium management <italic>(GCNT3, ANLN, S100A14, S100P</italic>), and structural integrity of epithelial cells (<italic>ITGA2, ITGA3, KRT19</italic>). Most of the genes reinter the importance of the ECM interaction and cellular morphology in carcinogenic processes in PDAC. The AOX1 was the only downregulated gene in PDAC compared to normal samples. The AOX1 was already detected as downregulated in other PDAC studies [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>], and this corroborates the result presented here.</p>
    </sec>
    <sec id="Sec11">
      <title>Immunohistochemical staining images validation</title>
      <p id="Par38">To determine whether the CG is also present as proteins expressed in PDAC, we investigated the expression of these genes in HPA. This analysis could confirm the protein expression from many of the CG list using information from IHC staining images. The protein expression data from the CG showed that 14 genes have more than 75% of images with high or medium expression in pancreatic cancer (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). More than 75% of IHC images stained for KRT19 and S100P showed high expression values of these genes at the protein level (Fig. <xref rid="Fig3" ref-type="fig">3</xref>), from a set of 23 and 12 images in HPA, respectively.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Variation in protein expression data from the GC list retrieved from immunohistochemical staining images in HPA. The protein expression data shows that 14 genes have more than 75% of images with high plus medium expression in pancreatic cancer, evidencing the expression of predicted core-genes in the pancreatic tissue. The genes with protein expression confirmed in IHC staining images were highlighted in red. Data credit: Human Protein Atlas</p></caption><graphic xlink:href="12885_2020_6533_Fig2_HTML" id="MO2"/></fig>
<fig id="Fig3"><label>Fig. 3</label><caption><p>Representative immunohistochemistry staining of AHNAK2, KRT19, LAMB2, LAMC2, and S100P in Pancreatic Ductal Adenocarcinoma (Tumor) and normal pancreatic tissue (Normal). The proteins presented more than 75% of images with high plus medium expression in HPA. Scales bars represent 400 μm. Image courtesy of Human Protein Atlas</p></caption><graphic xlink:href="12885_2020_6533_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par39">The genes CXCL5, GJB2, IFI27, and SLPI, have a low or no expression detected in at least 90% of samples, not corroborating with the CG list. The protein AOX1 presents a different expression between the RNA and protein levels. The AOX1 protein is highly expressed in some samples (60%) and low or not detected in others (40%) in HPA. There were three proteins (COL10A1, DKK1, and TCN1) with no information in HPA; thus, it is not possible to report about the protein expression in pancreatic cancer. All these data show essential genes in PDAC highly expressed in proteins level, confirming 14 genes from the CG in pancreatic cancer.</p>
    </sec>
    <sec id="Sec12">
      <title>Classification of the merged samples in tumor and control using PCA and hierarchical clustering</title>
      <p id="Par40">We performed hierarchical clustering of the samples/genes and a PCA analysis of the samples to evaluate how different the gene expression is among the samples and how the samples cluster. The PCA showed variation in the expression in a continuous manner, and some PDAC samples mixed with normal samples. Although this continuum between the normal and PDAC samples, the PCA plot has a region with only PDAC samples, indicating more specific gene expression in PDAC. The PCA result indicates a difference in the CG expression enough to classify the samples in normal and PDAC; however, the PCA does not predict the label of the sample (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S1). The continuum and mixture of samples indicate that some samples present a different gene expression pattern and are closer to samples from the other group.</p>
      <p id="Par41">The hierarchical clustering, performed using CG expression standardized values from all ten datasets, reveals the presence of two groups, and it is possible to check the error of the sample classification (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). The standardized CG expression values were able to classify the data into two groups in a continuous manner, once more indicating that these groups exhibit distinctly cellular processes and functions. The hierarchical clustering showed the ratio Normal Classified/Normal = 85.5 and Tumor Classified/Tumor = 85.6.
<fig id="Fig4"><label>Fig. 4</label><caption><p>PCA and hierarchical analysis of the merged data set into one data. <bold>a</bold>. PCA analysis clearly showed two distinct groups corresponding to normal and tumor samples. <bold>b</bold>. Clustering analysis. The red band indicates the PDAC samples with similar gene expression on 40-core-gene, and the blue band indicates the normal samples</p></caption><graphic xlink:href="12885_2020_6533_Fig4_HTML" id="MO4"/></fig></p>
      <p id="Par42">The methodology was also applied to independent datasets (GSE16515 and GSE62452) to validate the CG found in the meta-analysis. The CG expression values from these independent datasets produced similar results in both PCA and heatmap hierarchical clustering analysis (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S1). The PCA and heatmap showed that CG could classify the data in two groups of normal and tumoral samples, which suggest that the CG maps central process in PDAC. Together, these results indicate that the CG expression can distinguish the groups normal from PDAC samples, with different functional/cellular processes expressed by this condition, and this points to CG list as critical genes in PDAC that could be used to classify the samples and improve diagnosis.</p>
    </sec>
    <sec id="Sec13">
      <title>Neural network sample classification</title>
      <p id="Par43">The best neural network architecture had a mean accuracy of 88.1 and 85.71% in the train and test set respectively; the architecture has five input neurons, eight and ten neurons in the next two hidden layers, and two output. We selected the best-trained network with this architecture with an accuracy of 89.66. We examined the classification performance in the validation dataset using the f1-score, which summarize the precision and recall measurements (Table <xref rid="Tab3" ref-type="table">3</xref>). The f1-score was 0.83 for the normal samples and 0.88 for the PDAC samples, with an average of 0.86. The confusion matrix showed that the number of true negatives (normal) was 64/77, while the number of true positives is 92/105 (Table <xref rid="Tab4" ref-type="table">4</xref>).
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Classification report of the validation test set</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Precision</th><th>Recall</th><th>F1-score</th><th>Support</th></tr></thead><tbody><tr><td>Normal</td><td>0.83</td><td>0.83</td><td>0.83</td><td>77</td></tr><tr><td>Tumor</td><td>0.88</td><td>0.88</td><td>0.88</td><td>105</td></tr><tr><td>Avg/total</td><td>0.86</td><td>0.86</td><td>0.86</td><td>182</td></tr></tbody></table></table-wrap>
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Confusion matrix of the training and validation test samples</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th>Actual normal</th><th>Actual tumor</th></tr></thead><tbody><tr><td rowspan="3">Training</td><td>Classified normal</td><td>169</td><td>49</td></tr><tr><td>Classified tumor</td><td>18</td><td>412</td></tr><tr><td/><td>Specificity = 90.4</td><td>Sensitivity = 89.4</td></tr><tr><td rowspan="3">Test</td><td>Classified normal</td><td>64</td><td>13</td></tr><tr><td>Classified tumor</td><td>13</td><td>92</td></tr><tr><td/><td>Specificity = 83.1</td><td>Sensitivity = 87.6</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec14">
    <title>Discussion</title>
    <p id="Par44">We performed a meta-analysis of mRNA expression data recovered from public datasets, intending to investigate the profile of molecular alterations in pancreatic ductal adenocarcinoma and use this information to build an ANN predictor. Comparing 461 tumor samples to 187 normal tissues, we were able to observe a central group of genes linked to carcinogenic processes, labeled core-genes. Further, we investigated the protein expression with immunohistochemistry information recovery from HPA and validated with two independent microarrays through hierarchical clustering and PCA. The late diagnosis and high mortality rate in PDAC patients demand better tools to improve the diagnosis. Currently, the gold standard blood-based biomarker for PDAC diagnosis is the CA 19–9 [<xref ref-type="bibr" rid="CR54">54</xref>]. However, CA 19–9 lacks the sensitivity for the early detection and also has a poor predictive value in asymptomatic patients [<xref ref-type="bibr" rid="CR55">55</xref>–<xref ref-type="bibr" rid="CR57">57</xref>]. Imaging screening, like magnetic resonance imaging (MRI) and computed tomography (CT), while accurate, is expensive and uncomfortable [<xref ref-type="bibr" rid="CR58">58</xref>]. Thus, the precise selection of biomarkers can increase the accuracy in the diagnosis of PDAC as well as provide a cheaper diagnostic method with a lower invasion.</p>
    <p id="Par45">We performed a validation of the CG through the IHC images retrieved from HPA, and our results indicated a list of possible PDAC biomarkers. Furthermore, we presented a biomarker often used for PDAC diagnosis, the carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5, also known as CEA). The CEACAM5 has been pointed as the second serum biomarker most used clinically for detecting PDAC [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
    <p id="Par46">We confirmed the expression of 14 genes from CG with high expression in the protein level. These proteins are involved in many functions in cancer biology. For instance, the most expressed protein, keratin 19 (KRT19), is a structural protein of epithelial cells, with expression in a subset of pancreatic cells [<xref ref-type="bibr" rid="CR59">59</xref>]. The KRT19 was already described as a possible biomarker for PDAC, and patients with upregulation of KRT19 presents poor differentiation, large tumor size, lymph node metastasis, and invasion [<xref ref-type="bibr" rid="CR60">60</xref>]. In other gastrointestinal cancers, clinical-pathological analyses revel KRT19 correlated with metastasis, tumor size, microvascular invasion, decreased tumor differentiation, and also conferred an invasive phenotype [<xref ref-type="bibr" rid="CR60">60</xref>].</p>
    <p id="Par47">The laminin subunit gamma 2 (LAMC2) and beta 3 (LAMB3) proteins were shown to be upregulated in PDAC samples using microarray, immunohistochemical analyses, and biomarkers for diagnosis and prognosis integrating a multigene panel [<xref ref-type="bibr" rid="CR61">61</xref>–<xref ref-type="bibr" rid="CR63">63</xref>]. Proteomic analysis pointed the LAMC2 as a potential biomarker for PDAC, being upregulated with an mRNA fold of 8.36. The serum concentration of LAMC2 in patients with PDAC was ∼ 3.5-fold higher from benign and normal samples, indicating this gene as a promising biomarker [<xref ref-type="bibr" rid="CR64">64</xref>]. PDAC patients expressing the high amount of LAMC2 have a poor prognosis [<xref ref-type="bibr" rid="CR63">63</xref>], reinforcing this gene as a putative biomarker for diagnosis or prognosis. The LAMB3 is involved in the first stage and progression of PDAC, promotion of cell proliferation, inhibition of apoptosis, and is also involved in metastatic PDAC [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. These results showed the critical association of LAMC2 and LAMB3 with PDAC and highlighted them to be used as therapeutic targets in PDAC treatment [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR65">65</xref>].</p>
    <p id="Par48">The AHNAK Nucleoprotein 2 was already reported as a PDAC biomarker with tissue-based evidence, thus, confirming AHNAK2 expression in protein level [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. In our analysis, AHNAK2 was highly expressed in 23 of 45 PDAC samples, as indicated in the HPA results. The AHNAK2 function in PDAC in poorly described; however, another similar <italic>AHNAK</italic> gene is involved with migration and the epithelial-mesenchymal transition, indicating the AHNAK2 may be involved in these processes as well [<xref ref-type="bibr" rid="CR67">67</xref>]. AHNAK2 high expression is associated with PDAC poor prognosis and is also expressed in bladder and kidney cancer [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>].</p>
    <p id="Par49">The S100 Calcium Binding Protein P was reported as a useful biomarker for PDAC based on IHC with expression already reported in gastric and bladder cancer [<xref ref-type="bibr" rid="CR70">70</xref>]. In PDAC, S100P is expressed in precursor lesions and is involved with tumor growth and invasion [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. We showed that S100P was one of the three proteins detected with high expression based on IHC in HPA (6 of 9 samples). S100P was studied to discriminated normal and PDAC samples using a higher concentration in duodenal fluid in patients with PDAC compared with the control group, presenting an AUC of 0.71 for detecting PDAC [<xref ref-type="bibr" rid="CR73">73</xref>]. Our results showed an AUC of 0.92 for S100P using mRNA expression (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Figure S2). A meta-analysis study showed S100P as a potential biomarker to discriminate PDAC samples using RT-PCR or IHC and reported a sensitivity and a specificity of 0.87 and 0.88, respectively [<xref ref-type="bibr" rid="CR74">74</xref>].</p>
    <p id="Par50">In addition to IHC validation, the CG expression values were tested in independent samples. The PCA and the heatmap hierarchical clustering analysis indicated that CG plays a central process in PDAC and is capable of classifying the data in two groups of normal and tumoral samples. Although there were core regions with a higher number of normal or PDAC samples, some PDAC samples presented gene expression similar to normal samples and were misplaced in PCA. The microarray analysis using PCA already showed that higher dimensionality of the PCA, beyond the first two or three dimensions, can hold valuable information, thus limiting the PCA interpretations [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. The CG in these set of samples present a different pattern, and it is not possible correctly assigning them based on this gene expression. The use of ANN could increase the correct classification, leading to higher sensitivity. Even though, in the validation dataset, 13 samples in each group were incorrectly classified, pointing a limitation.</p>
    <p id="Par51">We used five genes to develop an ANN sample classifier. We achieve sensitivity and specificity of 87.6 and 81.8%, respectively, applying our ANN classifier in the test set. The development of automatic classifiers based on artificial intelligence can aid the PDAC diagnosis. Five possible PDAC biomarkers were already pointed (FAIM3, IRANK3, DENND2D, PLBD1, AGPAT) based on gene expression, achieving a combined sensitivity of 100% and specificity of 94% [<xref ref-type="bibr" rid="CR77">77</xref>]; however, no automatic classification was produced. These five genes were pointed as potential biomarkers in PDAC diagnosis. Here, we not only pointed five genes independently differentially expressed among datasets but also created an automatic tool to classify the samples and give the probability of being normal or PDAC. In contrast with the list of five differentially genes reported by Irigoyen et al. 2018 [<xref ref-type="bibr" rid="CR77">77</xref>], the CG list reported here did not include any of these genes.</p>
    <p id="Par52">In another study, artificial intelligence was developed with support vector machines (SVM) to classify samples using PDAC gene expression information of five genes (TMPRSS4, AHNAK2, POSTN, ECT2, and SERPINB5). Using different genes, our ANN has different results compared with the PDAC SVM classifier that showed validation dataset sensitivity 88.89–97.22% and specificity of 85.7–96.5% [<xref ref-type="bibr" rid="CR16">16</xref>]. The variation of sensitivity and specificity indicates that the SVM classifier has better performance in some datasets. While our ANN was applied to all validation samples at once and the values of sensitivity and specificity are closer to the potential of classifying PDAC samples based on gene expression. The datasets used in both works are different, with this in mind, sample preparation or microarray technologies (Affymetrix and Illumina) could be possible explanations to different gene lists. Furthermore, the use of ten datasets here in contrast with two datasets by Irigoyen et al. 2018 [<xref ref-type="bibr" rid="CR77">77</xref>] could also produce different results. Another explanation for these differences in the gene list presented here could be due to PDAC subtypes already studied in gene expression and clinical level [<xref ref-type="bibr" rid="CR10">10</xref>].</p>
  </sec>
  <sec id="Sec15">
    <title>Conclusions</title>
    <p id="Par53">The results indicated that PDAC presents a 40-core gene signature, with 39 genes upregulated and one downregulated. Among these upregulated genes, many are related to cell adhesion, migration, and extracellular matrix-receptor interaction; the downregulated gene is associated with pancreatic functions. Immunohistochemical analyses confirm the overexpression at the protein level of 14 genes, validating our analysis. The five most overexpressed genes were related to tumor differentiation, cell migration, and metastasis. The PDAC-ANN trained using gene expression information could classify the samples in normal and PDAC with an f1-score of 0.82 and sensitivity 87.6. The ANN diagnosis tool can only be used when the gene expression information from AHNAK2, LAMB3, LAMC2, KRT19, and S100P are available, in addition to min-max gene expression values rescaling. The PDAC-ANN is a free tool that can support in the pancreatic ductal adenocarcinoma diagnosis.</p>
  </sec>
  <sec id="Sec16">
    <title>Availability and requirements</title>
    <p id="Par54">Project name: Pancreatic ductal adenocarcinoma artificial neural network (PDAC-ANN).</p>
    <p id="Par55">Project home page: <ext-link ext-link-type="uri" xlink:href="https://github.com/freitasleandro/PDAC-ANN">https://github.com/freitasleandro/PDAC-ANN</ext-link></p>
    <p id="Par56">Operating system(s): e.g. Platform independent.</p>
    <p id="Par57">Programming language: Python 3.7.</p>
    <p id="Par58">Other requirements: pandas, numpy, sklearn, keras, tensorflow, argparse.</p>
    <p id="Par59">License: GNU GPL v3.0.</p>
    <p id="Par60">Any restrictions to use by non-academics: licence needed.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec17">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12885_2020_6533_MOESM1_ESM.xls">
            <caption>
              <p><bold>Additional file 1: Table S1.</bold> Microarray gene expression results from the six studies here. Excel file with information of spot ID, adjusted <italic>p</italic>-value ≤0.05, |log2FC| ≥ 1,Gene symbol, Gene.ID (ENTREZ_GENE_ID).</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="12885_2020_6533_MOESM2_ESM.pdf">
            <caption>
              <p><bold>Additional file 2: Figure S1.</bold> PCA and hierarchical analysis of the CG expression values from GSE16515. (a) The CG could produce similar results in both PCA and (b) heatmap hierarchical clustering analysis. The CG can classify the data into two groups of normal and tumoral samples.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="12885_2020_6533_MOESM3_ESM.xls">
            <caption>
              <p><bold>Additional file 3: Table S2.</bold> Excel file with links to protein expression level from the CG and links to immunohistochemical images available in HPA.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM4">
          <media xlink:href="12885_2020_6533_MOESM4_ESM.pdf">
            <caption>
              <p><bold>Additional file 4: Figure S2.</bold> Receiver operating characteristic (ROC) curve for the five genes selected to train the ANN. The AUC was used to select the genes to train the ANN. The genes selected were AHNAK2 (92.2), KRT19 (92.6), LAMB2 (93.3), LAMC2 (91.8), and S100P (92.3). The AUC for each gene is presented in the parentheses.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>AI</term>
        <def>
          <p id="Par5">Artificial intelligence</p>
        </def>
      </def-item>
      <def-item>
        <term>ANN</term>
        <def>
          <p id="Par6">Artificial neural network</p>
        </def>
      </def-item>
      <def-item>
        <term>AUC</term>
        <def>
          <p id="Par7">Area under the curve</p>
        </def>
      </def-item>
      <def-item>
        <term>CAPES</term>
        <def>
          <p id="Par8">Coordination of Improvement of Higher Education Personnel</p>
        </def>
      </def-item>
      <def-item>
        <term>CG</term>
        <def>
          <p id="Par9">Core-genes</p>
        </def>
      </def-item>
      <def-item>
        <term>CT</term>
        <def>
          <p id="Par10">Computed tomography</p>
        </def>
      </def-item>
      <def-item>
        <term>DEG</term>
        <def>
          <p id="Par11">Differentially expressed genes</p>
        </def>
      </def-item>
      <def-item>
        <term>ECM</term>
        <def>
          <p id="Par12">Extracellular matrix</p>
        </def>
      </def-item>
      <def-item>
        <term>GEO</term>
        <def>
          <p id="Par13">Gene Expression Omnibus</p>
        </def>
      </def-item>
      <def-item>
        <term>IHC</term>
        <def>
          <p id="Par14">Immunohistochemical</p>
        </def>
      </def-item>
      <def-item>
        <term>MRI</term>
        <def>
          <p id="Par15">Magnetic resonance imaging</p>
        </def>
      </def-item>
      <def-item>
        <term>mRNA</term>
        <def>
          <p id="Par16">messenger RNA</p>
        </def>
      </def-item>
      <def-item>
        <term>PCA</term>
        <def>
          <p id="Par17">Principal component analysis</p>
        </def>
      </def-item>
      <def-item>
        <term>PDAC</term>
        <def>
          <p id="Par18">Pancreatic ductal adenocarcinoma</p>
        </def>
      </def-item>
      <def-item>
        <term>PNPD</term>
        <def>
          <p id="Par19">National Postdoctoral Program</p>
        </def>
      </def-item>
      <def-item>
        <term>ROC</term>
        <def>
          <p id="Par20">Receiver operating characteristic</p>
        </def>
      </def-item>
      <def-item>
        <term>SVM</term>
        <def>
          <p id="Par21">Support vector machine</p>
        </def>
      </def-item>
      <def-item>
        <term>HPA</term>
        <def>
          <p id="Par22">Human Protein Atlas</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s12885-020-6533-0.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>LMF conceived the idea. LMF wrote the scripts. PPA and LMF carried out the gene expression bioinformatics analyses, CPC carried out the protein expression analysis. All coauthors are involved in interpreting the results, developing the discussion section, and writing the manuscript. All coauthors have read and agreed with the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported by PNPD/CAPES fellowship from UFBA/Biociências postgraduate program. The authors confirm that the funding agency did not influence the study design, data collection, interpretation of results, and selection of this journal.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The datasets analyzed during the current study are available in the GEO repository under accession numbers GSE23397, GSE28735, GSE32676, GSE41368, GSE43795, GSE71989, GSE15471, GSE62165, GSE71729, GSE60979, GSE62452, and GSE16515.</p>
    <p>The immunohistochemistry images and antibody staining levels are available in HPA (<ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org">https://www.proteinatlas.org</ext-link>). Links to antibody staining levels and images are submitted as Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S2.</p>
  </notes>
  <notes>
    <title>Ethics approval and consent to participate</title>
    <p id="Par61">Not applicable.</p>
  </notes>
  <notes>
    <title>Consent for publication</title>
    <p id="Par62">Not applicable.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par63">The authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Siegel</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Jemal</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Cancer statistics, 2018</article-title>
        <source>CA Cancer J Clin</source>
        <year>2018</year>
        <volume>68</volume>
        <fpage>7</fpage>
        <lpage>30</lpage>
        <pub-id pub-id-type="doi">10.3322/caac.21442</pub-id>
        <?supplied-pmid 29313949?>
        <pub-id pub-id-type="pmid">29313949</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hong</surname>
            <given-names>S-M</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Hruban</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Goggins</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Molecular signatures of pancreatic cancer</article-title>
        <source>Arch Pathol Lab Med</source>
        <year>2011</year>
        <volume>135</volume>
        <fpage>716</fpage>
        <lpage>727</lpage>
        <pub-id pub-id-type="doi">10.1043/2010-0566-RA.1</pub-id>
        <?supplied-pmid 21631264?>
        <pub-id pub-id-type="pmid">21631264</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Collins</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Bednar</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Brisset</surname>
            <given-names>J-C</given-names>
          </name>
          <name>
            <surname>Galbán</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Galbán</surname>
            <given-names>CJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice</article-title>
        <source>J Clin Invest</source>
        <year>2012</year>
        <volume>122</volume>
        <fpage>639</fpage>
        <lpage>653</lpage>
        <pub-id pub-id-type="doi">10.1172/JCI59227</pub-id>
        <?supplied-pmid 22232209?>
        <pub-id pub-id-type="pmid">22232209</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wilentz</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Geradts</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Maynard</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Offerhaus</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Goggins</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression</article-title>
        <source>Cancer Res</source>
        <year>1998</year>
        <volume>58</volume>
        <fpage>4740</fpage>
        <lpage>4744</lpage>
        <?supplied-pmid 9788631?>
        <pub-id pub-id-type="pmid">9788631</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hahn</surname>
            <given-names>S a</given-names>
          </name>
          <name>
            <surname>Schutte</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>ATMS</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Moskaluk</surname>
            <given-names>C a</given-names>
          </name>
          <name>
            <surname>da Costa</surname>
            <given-names>LT</given-names>
          </name>
          <name>
            <surname>Rozenblum</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1</article-title>
        <source>Science (80- )</source>
        <year>1996</year>
        <volume>271</volume>
        <fpage>350</fpage>
        <lpage>353</lpage>
        <pub-id pub-id-type="doi">10.1126/science.271.5247.350</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rozenblum</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Schutte</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Goggins</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hahn</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Panzer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zahurak</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tumor-suppressive pathways in pancreatic carcinoma</article-title>
        <source>Cancer Res</source>
        <year>1997</year>
        <volume>57</volume>
        <fpage>1731</fpage>
        <lpage>1734</lpage>
        <?supplied-pmid 9135016?>
        <pub-id pub-id-type="pmid">9135016</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sahin</surname>
            <given-names>IH</given-names>
          </name>
          <name>
            <surname>Iacobuzio-Donahue</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>O’Reilly</surname>
            <given-names>EM</given-names>
          </name>
        </person-group>
        <article-title>Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy</article-title>
        <source>Expert Opin Ther Targets</source>
        <year>2016</year>
        <volume>20</volume>
        <fpage>341</fpage>
        <lpage>359</lpage>
        <pub-id pub-id-type="doi">10.1517/14728222.2016.1094057</pub-id>
        <?supplied-pmid 26439702?>
        <pub-id pub-id-type="pmid">26439702</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McCormick</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>KRAS as a therapeutic target</article-title>
        <source>Clin Cancer Res</source>
        <year>2015</year>
        <volume>21</volume>
        <fpage>1797</fpage>
        <lpage>1801</lpage>
        <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-14-2662</pub-id>
        <pub-id pub-id-type="pmid">25878360</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeitouni</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pylayeva-Gupta</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Der</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bryant</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment</article-title>
        <source>Cancers (Basel)</source>
        <year>2016</year>
        <volume>8</volume>
        <fpage>45</fpage>
        <pub-id pub-id-type="doi">10.3390/cancers8040045</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes</article-title>
        <source>BMC Cancer</source>
        <year>2018</year>
        <volume>18</volume>
        <fpage>603</fpage>
        <pub-id pub-id-type="doi">10.1186/s12885-018-4546-8</pub-id>
        <?supplied-pmid 29843660?>
        <pub-id pub-id-type="pmid">29843660</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raphael</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Hruban</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Aguirre</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Moffitt</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Yeh</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Stewart</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma</article-title>
        <source>Cancer Cell</source>
        <year>2017</year>
        <volume>32</volume>
        <fpage>185</fpage>
        <lpage>203.e13</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ccell.2017.07.007</pub-id>
        <pub-id pub-id-type="pmid">28810144</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yeo</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Lowy</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Baldwin</surname>
            <given-names>GS</given-names>
          </name>
          <name>
            <surname>Nikfarjam</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine</article-title>
        <source>BMC Cancer</source>
        <year>2016</year>
        <volume>16</volume>
        <fpage>24</fpage>
        <pub-id pub-id-type="doi">10.1186/s12885-016-2057-z</pub-id>
        <?supplied-pmid 26774265?>
        <pub-id pub-id-type="pmid">26774265</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Janky</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Binda</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Allemeersch</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Van den broeck</surname>
            <given-names>a</given-names>
          </name>
          <name>
            <surname>Govaere</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Swinnen</surname>
            <given-names>JV</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma</article-title>
        <source>BMC Cancer</source>
        <year>2016</year>
        <volume>16</volume>
        <fpage>632</fpage>
        <pub-id pub-id-type="doi">10.1186/s12885-016-2540-6</pub-id>
        <?supplied-pmid 27520560?>
        <pub-id pub-id-type="pmid">27520560</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jagadeeshan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Venkatraman</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Rayala</surname>
            <given-names>SK</given-names>
          </name>
        </person-group>
        <article-title>Targeting p21 activated kinase 1 (Pak1) to PAKup pancreatic Cancer</article-title>
        <source>Expert Opin Ther Targets</source>
        <year>2016</year>
        <volume>20</volume>
        <fpage>1283</fpage>
        <lpage>1285</lpage>
        <pub-id pub-id-type="doi">10.1080/14728222.2016.1239719</pub-id>
        <?supplied-pmid 27654702?>
        <pub-id pub-id-type="pmid">27654702</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shen</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>J-K</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W-X</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>Y-W</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>H-Z</given-names>
          </name>
        </person-group>
        <article-title>Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma</article-title>
        <source>Med Sci Monit</source>
        <year>2018</year>
        <volume>24</volume>
        <fpage>2368</fpage>
        <lpage>2376</lpage>
        <pub-id pub-id-type="doi">10.12659/MSM.906313</pub-id>
        <?supplied-pmid 29671412?>
        <pub-id pub-id-type="pmid">29671412</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bhasin</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Ndebele</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bucur</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Yee</surname>
            <given-names>EU</given-names>
          </name>
          <name>
            <surname>Otu</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Plati</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <fpage>23263</fpage>
        <lpage>23281</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.8139</pub-id>
        <?supplied-pmid 26993610?>
        <pub-id pub-id-type="pmid">26993610</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhavoronkov</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Artificial intelligence for drug discovery, biomarker development, and generation of novel chemistry</article-title>
        <source>Mol Pharm</source>
        <year>2018</year>
        <volume>15</volume>
        <fpage>4311</fpage>
        <lpage>4313</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.8b00930</pub-id>
        <?supplied-pmid 30269508?>
        <pub-id pub-id-type="pmid">30269508</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Ringnér</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Saal</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Ladanyi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Westermann</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks</article-title>
        <source>Nat Med</source>
        <year>2001</year>
        <volume>7</volume>
        <fpage>673</fpage>
        <lpage>679</lpage>
        <pub-id pub-id-type="doi">10.1038/89044</pub-id>
        <?supplied-pmid 11385503?>
        <pub-id pub-id-type="pmid">11385503</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Weighted K-means support vector machine for cancer prediction</article-title>
        <source>Springerplus.</source>
        <year>2016</year>
        <volume>5</volume>
        <fpage>1162</fpage>
        <pub-id pub-id-type="doi">10.1186/s40064-016-2677-4</pub-id>
        <?supplied-pmid 27512621?>
        <pub-id pub-id-type="pmid">27512621</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Golub</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Slonim</surname>
            <given-names>DK</given-names>
          </name>
          <name>
            <surname>Tamayo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Huard</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gaasenbeek</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mesirov</surname>
            <given-names>JP</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Molecular classification of cancer: class discovery and class prediction by gene expression monitoring</article-title>
        <source>Science.</source>
        <year>1999</year>
        <volume>286</volume>
        <fpage>531</fpage>
        <lpage>537</lpage>
        <pub-id pub-id-type="doi">10.1126/science.286.5439.531</pub-id>
        <pub-id pub-id-type="pmid">10521349</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alkuhlani</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nassef</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Farag</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Multistage feature selection approach for high-dimensional cancer data</article-title>
        <source>Soft Comput</source>
        <year>2017</year>
        <volume>21</volume>
        <fpage>6895</fpage>
        <lpage>6906</lpage>
        <pub-id pub-id-type="doi">10.1007/s00500-016-2439-9</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Honda</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hayashida</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Umaki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Okusaka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kosuge</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kikuchi</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Possible detection of pancreatic Cancer by plasma protein profiling</article-title>
        <source>Cancer Res</source>
        <year>2005</year>
        <volume>65</volume>
        <fpage>10613</fpage>
        <lpage>10622</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-1851</pub-id>
        <?supplied-pmid 16288055?>
        <pub-id pub-id-type="pmid">16288055</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sweilam</surname>
            <given-names>NH</given-names>
          </name>
          <name>
            <surname>Tharwat</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Abdel Moniem</surname>
            <given-names>NK</given-names>
          </name>
        </person-group>
        <article-title>Support vector machine for diagnosis cancer disease: a comparative study</article-title>
        <source>Egypt Informatics J</source>
        <year>2010</year>
        <volume>11</volume>
        <fpage>81</fpage>
        <lpage>92</lpage>
        <pub-id pub-id-type="doi">10.1016/j.eij.2010.10.005</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hsieh</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L-M</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>C-L</given-names>
          </name>
          <name>
            <surname>Hsieh</surname>
            <given-names>M-J</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>C-Y</given-names>
          </name>
          <name>
            <surname>Kao</surname>
            <given-names>C-H</given-names>
          </name>
        </person-group>
        <article-title>Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models</article-title>
        <source>Cancer Manag Res</source>
        <year>2018</year>
        <volume>10</volume>
        <fpage>6317</fpage>
        <lpage>6324</lpage>
        <pub-id pub-id-type="doi">10.2147/CMAR.S180791</pub-id>
        <?supplied-pmid 30568493?>
        <pub-id pub-id-type="pmid">30568493</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Segal</surname>
            <given-names>NH</given-names>
          </name>
          <name>
            <surname>Pavlidis</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Antonescu</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Maki</surname>
            <given-names>RG</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>WS</given-names>
          </name>
          <name>
            <surname>DeSantis</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Classification and subtype prediction of adult soft tissue sarcoma by functional genomics</article-title>
        <source>Am J Pathol</source>
        <year>2003</year>
        <volume>163</volume>
        <fpage>691</fpage>
        <lpage>700</lpage>
        <pub-id pub-id-type="doi">10.1016/S0002-9440(10)63696-6</pub-id>
        <?supplied-pmid 12875988?>
        <pub-id pub-id-type="pmid">12875988</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Segal</surname>
            <given-names>NH</given-names>
          </name>
          <name>
            <surname>Pavlidis</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>WS</given-names>
          </name>
          <name>
            <surname>Antonescu</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Viale</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wesley</surname>
            <given-names>UV</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling</article-title>
        <source>J Clin Oncol</source>
        <year>2003</year>
        <volume>21</volume>
        <fpage>1775</fpage>
        <lpage>1781</lpage>
        <pub-id pub-id-type="doi">10.1200/JCO.2003.10.108</pub-id>
        <?supplied-pmid 12721254?>
        <pub-id pub-id-type="pmid">12721254</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Muhammad</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hart</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Nartowt</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Farrell</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Johung</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Pancreatic Cancer prediction through an artificial neural network</article-title>
        <source>Front Artif Intell</source>
        <year>2019</year>
        <volume>2</volume>
        <fpage>2</fpage>
        <pub-id pub-id-type="doi">10.3389/frai.2019.00002</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <mixed-citation publication-type="other">Man + Machine: Using Deep Learning for Early Detection of Pancreatic Cancer. 2018. <ext-link ext-link-type="uri" xlink:href="https://letswinpc.org/promising-science/2018/08/13/deep-learning-for-early-detection-of-pancreatic-cancer/">https://letswinpc.org/promising-science/2018/08/13/deep-learning-for-early-detection-of-pancreatic-cancer/</ext-link>. .</mixed-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Schetter</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Funamizu</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gaedcke</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ghadimi</surname>
            <given-names>BM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DPEP1 inhibits tumor cell invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma</article-title>
        <source>PLoS One</source>
        <year>2012</year>
        <volume>7</volume>
        <fpage>e31507</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0031507</pub-id>
        <?supplied-pmid 22363658?>
        <pub-id pub-id-type="pmid">22363658</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Frampton</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Castellano</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Colombo</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Giovannetti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Krell</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jacob</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression</article-title>
        <source>Gastroenterology</source>
        <year>2014</year>
        <volume>146</volume>
        <fpage>268</fpage>
        <lpage>277.e18</lpage>
        <pub-id pub-id-type="doi">10.1053/j.gastro.2013.10.010</pub-id>
        <?supplied-pmid 24120476?>
        <pub-id pub-id-type="pmid">24120476</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Donahue</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Tran</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kovochich</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Calvopina</surname>
            <given-names>JH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrative survival-based molecular profiling of human pancreatic Cancer</article-title>
        <source>Clin Cancer Res</source>
        <year>2012</year>
        <volume>18</volume>
        <fpage>1352</fpage>
        <lpage>1363</lpage>
        <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-1539</pub-id>
        <?supplied-pmid 22261810?>
        <pub-id pub-id-type="pmid">22261810</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Azevedo-Pouly</surname>
            <given-names>ACP</given-names>
          </name>
          <name>
            <surname>Redis</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Gusev</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Allard</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <fpage>53165</fpage>
        <lpage>53177</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.10242</pub-id>
        <?supplied-pmid 27363020?>
        <pub-id pub-id-type="pmid">27363020</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Badea</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Herlea</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Dima</surname>
            <given-names>SO</given-names>
          </name>
          <name>
            <surname>Dumitrascu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Popescu</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia</article-title>
        <source>Hepatogastroenterology.</source>
        <year>2008</year>
        <volume>55</volume>
        <fpage>2016</fpage>
        <lpage>2027</lpage>
        <?supplied-pmid 19260470?>
        <pub-id pub-id-type="pmid">19260470</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Park</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hwang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>WK</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>SK</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Characterization of gene expression and activated signaling pathways in solid-pseudopapillary neoplasm of pancreas</article-title>
        <source>Mod Pathol</source>
        <year>2014</year>
        <volume>27</volume>
        <fpage>580</fpage>
        <lpage>593</lpage>
        <pub-id pub-id-type="doi">10.1038/modpathol.2013.154</pub-id>
        <?supplied-pmid 24072181?>
        <pub-id pub-id-type="pmid">24072181</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moffitt</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Marayati</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Flate</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Volmar</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Loeza</surname>
            <given-names>SGH</given-names>
          </name>
          <name>
            <surname>Hoadley</surname>
            <given-names>KA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma</article-title>
        <source>Nat Genet</source>
        <year>2015</year>
        <volume>47</volume>
        <fpage>1168</fpage>
        <lpage>1178</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3398</pub-id>
        <?supplied-pmid 26343385?>
        <pub-id pub-id-type="pmid">26343385</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sandhu</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Bowitz Lothe</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Labori</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Lingjaerde</surname>
            <given-names>OC</given-names>
          </name>
          <name>
            <surname>Buanes</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Dalsgaard</surname>
            <given-names>AM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas</article-title>
        <source>Mol Oncol</source>
        <year>2015</year>
        <volume>9</volume>
        <fpage>758</fpage>
        <lpage>771</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molonc.2014.12.002</pub-id>
        <?supplied-pmid 25579086?>
        <pub-id pub-id-type="pmid">25579086</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pei</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Fridley</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Kalari</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Lingle</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>FKBP51 affects Cancer cell response to chemotherapy by negatively regulating Akt</article-title>
        <source>Cancer Cell</source>
        <year>2009</year>
        <volume>16</volume>
        <fpage>259</fpage>
        <lpage>266</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ccr.2009.07.016</pub-id>
        <?supplied-pmid 19732725?>
        <pub-id pub-id-type="pmid">19732725</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Schetter</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Funamizu</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A novel MIF signaling pathway drives the malignant character of pancreatic Cancer by targeting NR3C2</article-title>
        <source>Cancer Res</source>
        <year>2016</year>
        <volume>76</volume>
        <fpage>3838</fpage>
        <lpage>3850</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-2841</pub-id>
        <?supplied-pmid 27197190?>
        <pub-id pub-id-type="pmid">27197190</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>R Development Core Team</collab>
        </person-group>
        <source>Computational Many-Particle Physics</source>
        <year>2008</year>
        <publisher-loc>Berlin, Heidelberg</publisher-loc>
        <publisher-name>Springer Berlin Heidelberg</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Davis</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Meltzer</surname>
            <given-names>PS</given-names>
          </name>
        </person-group>
        <article-title>GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor</article-title>
        <source>Bioinformatics.</source>
        <year>2007</year>
        <volume>23</volume>
        <fpage>1846</fpage>
        <lpage>1847</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btm254</pub-id>
        <?supplied-pmid 17496320?>
        <pub-id pub-id-type="pmid">17496320</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gentleman</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Carey</surname>
            <given-names>VJ</given-names>
          </name>
          <name>
            <surname>Bates</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Bolstad</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dettling</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dudoit</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Bioconductor: open software development for computational biology and bioinformatics</article-title>
        <source>Genome Biol</source>
        <year>2004</year>
        <volume>5</volume>
        <fpage>R80</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2004-5-10-r80</pub-id>
        <pub-id pub-id-type="pmid">15461798</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <mixed-citation publication-type="other">Gentleman R, Carey V, Huber W, Hahne F. genefilter: methods for filtering genes from high-throughput experiments. 2017.</mixed-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Miller</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Langfelder</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Geschwind</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Kurian</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Salomon</surname>
            <given-names>DR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Strategies for aggregating gene expression data: the collapseRows R function</article-title>
        <source>BMC Bioinformatics</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>322</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-12-322</pub-id>
        <?supplied-pmid 21816037?>
        <pub-id pub-id-type="pmid">21816037</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ritchie</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Phipson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Law</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>
        <source>Nucleic Acids Res</source>
        <year>2015</year>
        <volume>43</volume>
        <fpage>e47</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
        <?supplied-pmid 4402510?>
        <pub-id pub-id-type="pmid">25605792</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benjamini</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hochberg</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Controlling the false discovery rate - a practical and powerful approach to multiple testing</article-title>
        <source>J Roy Stat Soc B Met</source>
        <year>1995</year>
        <volume>57</volume>
        <fpage>289</fpage>
        <lpage>300</lpage>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benjamini</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Discovering the false discovery rate</article-title>
        <source>J R Stat Soc Ser B</source>
        <year>2010</year>
        <volume>72</volume>
        <fpage>405</fpage>
        <lpage>416</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1467-9868.2010.00746.x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shabalin</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Tjelmeland</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Perou</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Nobel</surname>
            <given-names>AB</given-names>
          </name>
        </person-group>
        <article-title>Merging two gene-expression studies via cross-platform normalization</article-title>
        <source>Bioinformatics.</source>
        <year>2008</year>
        <volume>24</volume>
        <fpage>1154</fpage>
        <lpage>1160</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btn083</pub-id>
        <?supplied-pmid 18325927?>
        <pub-id pub-id-type="pmid">18325927</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sîrbu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ruskin</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Crane</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Cross-platform microarray data normalisation for regulatory network inference</article-title>
        <source>PLoS One</source>
        <year>2010</year>
        <volume>5</volume>
        <fpage>e13822</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0013822</pub-id>
        <?supplied-pmid 21103045?>
        <pub-id pub-id-type="pmid">21103045</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Uhlén</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Björling</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Agaton</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Szigyarto</surname>
            <given-names>CA-K</given-names>
          </name>
          <name>
            <surname>Amini</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Andersen</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A human protein atlas for Normal and Cancer tissues based on antibody proteomics</article-title>
        <source>Mol Cell Proteomics</source>
        <year>2005</year>
        <volume>4</volume>
        <fpage>1920</fpage>
        <lpage>1932</lpage>
        <pub-id pub-id-type="doi">10.1074/mcp.M500279-MCP200</pub-id>
        <?supplied-pmid 16127175?>
        <pub-id pub-id-type="pmid">16127175</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <mixed-citation publication-type="other">R Core Team. R: A Language and Environment for Statistical Computing. 2010.</mixed-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ginestet</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>ggplot2: elegant graphics for data analysis</article-title>
        <source>J R Stat Soc Ser A</source>
        <year>2011</year>
        <volume>174</volume>
        <fpage>245</fpage>
        <lpage>246</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1467-985X.2010.00676_9.x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Crnogorac-Jurcevic</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gangeswaran</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bhakta</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Capurso</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Lattimore</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Akada</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Proteomic Analysis of Chronic Pancreatitis and Pancreatic Adenocarcinoma</article-title>
        <source>Gastroenterology</source>
        <year>2005</year>
        <volume>129</volume>
        <fpage>1454</fpage>
        <lpage>1463</lpage>
        <pub-id pub-id-type="doi">10.1053/j.gastro.2005.08.012</pub-id>
        <?supplied-pmid 16285947?>
        <pub-id pub-id-type="pmid">16285947</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pilarsky</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ammerpohl</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Sipos</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dahl</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hartmann</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wellmann</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling</article-title>
        <source>J Cell Mol Med</source>
        <year>2008</year>
        <volume>12</volume>
        <fpage>2823</fpage>
        <lpage>2835</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1582-4934.2008.00289.x</pub-id>
        <?supplied-pmid 18298655?>
        <pub-id pub-id-type="pmid">18298655</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>E. Poruk</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Z. Gay</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>D. Mulvihill</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>M. Boucher</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>L. Scaife</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Clinical Utility of CA 19–9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates</article-title>
        <source>Curr Mol Med</source>
        <year>2013</year>
        <volume>13</volume>
        <fpage>340</fpage>
        <lpage>351</lpage>
        <pub-id pub-id-type="doi">10.2174/1566524011313030003</pub-id>
        <pub-id pub-id-type="pmid">23331006</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <mixed-citation publication-type="other">Balasenthil S, Huang Y, Liu S, Marsh T, Chen J, Stass SA, et al. A plasma biomarker panel to identify surgically Resectable early-stage pancreatic Cancer. JNCI J Natl Cancer Inst. 2017;109. 10.1093/jnci/djw341.</mixed-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ballehaninna</surname>
            <given-names>UK</given-names>
          </name>
          <name>
            <surname>Chamberlain</surname>
            <given-names>RS</given-names>
          </name>
        </person-group>
        <article-title>The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal</article-title>
        <source>J Gastrointest Oncol</source>
        <year>2012</year>
        <volume>3</volume>
        <fpage>105</fpage>
        <lpage>119</lpage>
        <?supplied-pmid 22811878?>
        <pub-id pub-id-type="pmid">22811878</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Swords</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Firpo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Scaife</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mulvihill</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Biomarkers in pancreatic adenocarcinoma: current perspectives</article-title>
        <source>Onco Targets Ther</source>
        <year>2016</year>
        <volume>9</volume>
        <fpage>7459</fpage>
        <lpage>7467</lpage>
        <pub-id pub-id-type="doi">10.2147/OTT.S100510</pub-id>
        <?supplied-pmid 28003762?>
        <pub-id pub-id-type="pmid">28003762</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sanagapalli</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Stoita</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Challenges in diagnosis of pancreatic cancer</article-title>
        <source>World J Gastroenterol</source>
        <year>2018</year>
        <volume>24</volume>
        <fpage>2047</fpage>
        <lpage>2060</lpage>
        <pub-id pub-id-type="doi">10.3748/wjg.v24.i19.2047</pub-id>
        <?supplied-pmid 29785074?>
        <pub-id pub-id-type="pmid">29785074</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moll</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Franke</surname>
            <given-names>WW</given-names>
          </name>
          <name>
            <surname>Schiller</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Geiger</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Krepler</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells</article-title>
        <source>Cell.</source>
        <year>1982</year>
        <volume>31</volume>
        <fpage>11</fpage>
        <lpage>24</lpage>
        <pub-id pub-id-type="doi">10.1016/0092-8674(82)90400-7</pub-id>
        <?supplied-pmid 6186379?>
        <pub-id pub-id-type="pmid">6186379</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yao</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Miao</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma</article-title>
        <source>Cancer Biomarkers</source>
        <year>2017</year>
        <volume>17</volume>
        <fpage>397</fpage>
        <lpage>404</lpage>
        <pub-id pub-id-type="doi">10.3233/CBM-160655</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <mixed-citation publication-type="other">Klett H, Fuellgraf H, Levit-Zerdoun E, Hussung S, Kowar S, Küsters S, et al. Identification and validation of a diagnostic and prognostic multi-gene biomarker panel for pancreatic ductal adenocarcinoma. Front Genet. 2018;9. 10.3389/fgene.2018.00108.</mixed-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma</article-title>
        <source>Aging (Albany NY)</source>
        <year>2019</year>
        <volume>11</volume>
        <fpage>3679</fpage>
        <lpage>3703</lpage>
        <pub-id pub-id-type="doi">10.18632/aging.102007</pub-id>
        <pub-id pub-id-type="pmid">31182680</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Fang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression</article-title>
        <source>Cancer Cell Int</source>
        <year>2018</year>
        <volume>18</volume>
        <fpage>214</fpage>
        <pub-id pub-id-type="doi">10.1186/s12935-018-0718-5</pub-id>
        <?supplied-pmid 30598639?>
        <pub-id pub-id-type="pmid">30598639</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kosanam</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Prassas</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Chrystoja</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Soleas</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dimitromanolakis</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Laminin, gamma 2 (LAMC2): a promising new putative pancreatic Cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues</article-title>
        <source>Mol Cell Proteomics</source>
        <year>2013</year>
        <volume>12</volume>
        <fpage>2820</fpage>
        <lpage>2832</lpage>
        <pub-id pub-id-type="doi">10.1074/mcp.M112.023507</pub-id>
        <?supplied-pmid 23798558?>
        <pub-id pub-id-type="pmid">23798558</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cheung</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway</article-title>
        <source>Cell Death Dis</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>230</fpage>
        <pub-id pub-id-type="doi">10.1038/s41419-019-1320-z</pub-id>
        <?supplied-pmid 30850586?>
        <pub-id pub-id-type="pmid">30850586</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yue</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>AHNAK2 is a potential prognostic biomarker in patients with PDAC</article-title>
        <source>Oncotarget</source>
        <year>2017</year>
        <volume>8</volume>
        <fpage>31775</fpage>
        <lpage>31784</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.15990</pub-id>
        <?supplied-pmid 28423668?>
        <pub-id pub-id-type="pmid">28423668</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dumitru</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Bankfalvi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zeidler</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Brandau</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lang</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma</article-title>
        <source>PLoS One</source>
        <year>2013</year>
        <volume>8</volume>
        <fpage>e56420</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0056420</pub-id>
        <?supplied-pmid 23409183?>
        <pub-id pub-id-type="pmid">23409183</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Witzke</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Großerueschkamp</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Jütte</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Horn</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Roghmann</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>von Landenberg</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrated Fourier transform infrared imaging and proteomics for identification of a candidate Histochemical biomarker in bladder Cancer</article-title>
        <source>Am J Pathol</source>
        <year>2019</year>
        <volume>189</volume>
        <fpage>619</fpage>
        <lpage>631</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajpath.2018.11.018</pub-id>
        <?supplied-pmid 30770125?>
        <pub-id pub-id-type="pmid">30770125</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>AHNAK2 is a novel prognostic marker and oncogenic protein for clear cell renal cell carcinoma</article-title>
        <source>Theranostics.</source>
        <year>2017</year>
        <volume>7</volume>
        <fpage>1100</fpage>
        <lpage>1113</lpage>
        <pub-id pub-id-type="doi">10.7150/thno.18198</pub-id>
        <?supplied-pmid 28435451?>
        <pub-id pub-id-type="pmid">28435451</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Crnogorac-Jurcevic</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Missiaglia</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Blaveri</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gangeswaran</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Terris</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent</article-title>
        <source>J Pathol</source>
        <year>2003</year>
        <volume>201</volume>
        <fpage>63</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="doi">10.1002/path.1418</pub-id>
        <?supplied-pmid 12950018?>
        <pub-id pub-id-type="pmid">12950018</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dowen</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Crnogorac-Jurcevic</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gangeswaran</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Eloranta</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Bhakta</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Expression of S100P and its novel binding partner S100PBPR in early pancreatic Cancer</article-title>
        <source>Am J Pathol</source>
        <year>2005</year>
        <volume>166</volume>
        <fpage>81</fpage>
        <lpage>92</lpage>
        <pub-id pub-id-type="doi">10.1016/S0002-9440(10)62234-1</pub-id>
        <?supplied-pmid 15632002?>
        <pub-id pub-id-type="pmid">15632002</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arumugam</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>S100P promotes pancreatic Cancer growth, survival, and invasion</article-title>
        <source>Clin Cancer Res</source>
        <year>2005</year>
        <volume>11</volume>
        <fpage>5356</fpage>
        <lpage>5364</lpage>
        <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-05-0092</pub-id>
        <?supplied-pmid 16061848?>
        <pub-id pub-id-type="pmid">16061848</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Matsunaga</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ohtsuka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Asano</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kimura</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ohuchida</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kitada</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>S100P in duodenal fluid is a useful diagnostic marker for pancreatic ductal adenocarcinoma</article-title>
        <source>Pancreas.</source>
        <year>2017</year>
        <volume>46</volume>
        <fpage>1288</fpage>
        <lpage>1295</lpage>
        <pub-id pub-id-type="doi">10.1097/MPA.0000000000000940</pub-id>
        <?supplied-pmid 28984789?>
        <pub-id pub-id-type="pmid">28984789</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Diagnostic value of S100P for pancreatic cancer: a meta-analysis</article-title>
        <source>Tumor Biol</source>
        <year>2014</year>
        <volume>35</volume>
        <fpage>9479</fpage>
        <lpage>9485</lpage>
        <pub-id pub-id-type="doi">10.1007/s13277-014-2461-4</pub-id>
      </element-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yeung</surname>
            <given-names>KY</given-names>
          </name>
          <name>
            <surname>Ruzzo</surname>
            <given-names>WL</given-names>
          </name>
        </person-group>
        <article-title>Principal component analysis for clustering gene expression data</article-title>
        <source>Bioinformatics.</source>
        <year>2001</year>
        <volume>17</volume>
        <fpage>763</fpage>
        <lpage>774</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/17.9.763</pub-id>
        <?supplied-pmid 11590094?>
        <pub-id pub-id-type="pmid">11590094</pub-id>
      </element-citation>
    </ref>
    <ref id="CR76">
      <label>76.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lenz</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Müller</surname>
            <given-names>F-J</given-names>
          </name>
          <name>
            <surname>Zenke</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schuppert</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Principal components analysis and the reported low intrinsic dimensionality of gene expression microarray data</article-title>
        <source>Sci Rep</source>
        <year>2016</year>
        <volume>6</volume>
        <fpage>25696</fpage>
        <pub-id pub-id-type="doi">10.1038/srep25696</pub-id>
        <?supplied-pmid 27254731?>
        <pub-id pub-id-type="pmid">27254731</pub-id>
      </element-citation>
    </ref>
    <ref id="CR77">
      <label>77.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Irigoyen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jimenez-Luna</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Benavides</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Caba</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Gallego</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ortuño</surname>
            <given-names>FM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers</article-title>
        <source>PLoS One</source>
        <year>2018</year>
        <volume>13</volume>
        <fpage>e0194844</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0194844</pub-id>
        <?supplied-pmid 29617451?>
        <pub-id pub-id-type="pmid">29617451</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
